Sajjan Daniel

Sajjan Daniel is an accomplished executive in drug safety and pharmacovigilance, currently serving as Vice President and Head of Drug Safety & Pharmacovigilance at Purdue Pharma L.P. since September 2020. With extensive experience across leading pharmaceutical companies, Sajjan Daniel held key positions including Vice President and Global Head of Drug Safety at Amicus Therapeutics, and Shire, and has held various senior roles at Baxalta, Takeda Pharmaceuticals, and Pfizer Pharmaceuticals. Sajjan Daniel's expertise also includes therapeutic area leadership in CNS, cardiovascular, and renal products. Academic credentials encompass a Bachelor of Science in Biology, Chemistry, and Business from the University at Albany, as well as a Medical Degree from Debrecen Medical University.